Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Laparoscopic splenectomy for solitary splenic tumors
Vadim Makrin
,
Shmuel Avital
*
,
Ian White
, Boaz Sagie
,
Amir Szold
*
Corresponding author for this work
Tel Aviv Sourasky Medical Center
Research output
:
Contribution to journal
›
Article
›
peer-review
33
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Laparoscopic splenectomy for solitary splenic tumors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Laparoscopic Splenectomy
100%
Splenic Tumor
100%
Splenic Mass
100%
Malignant Tumor
75%
Computed Tomography
50%
Spleen
50%
Benign Tumor
50%
Abdominal Pain
25%
Pancreas
25%
Paucity
25%
Telephone Interview
25%
Operative Time
25%
Weight Loss
25%
Solid Tumors
25%
Anemia
25%
Lymphoproliferative Disorders
25%
Malignant Lymphoma
25%
Non-Hodgkin Lymphoma
25%
Hospital Stay
25%
Abdominal Ultrasound
25%
Conversion Rate
25%
Stomach
25%
Organ Tissue
25%
Postoperative Mortality
25%
Mass Size
25%
Laparoscopic Treatment
25%
Patient Imaging
25%
Laparoscopic Management
25%
Massive Splenomegaly
25%
Palpable Abdominal Mass
25%
Solid Mass
25%
Preoperative Patients
25%
Inflammatory Pseudotumor
25%
Patient-reported Symptoms
25%
Evaluation Management
25%
Splenic Lesions
25%
Working Diagnosis
25%
Estimated Blood Loss
25%
Positron Emission Tomography/computed Tomography (PET/CT)
25%
Patient Chart
25%
Benign Lesions
25%
Medicine and Dentistry
Tumor
100%
Splenectomy
100%
Cancer
75%
Computer Assisted Tomography
50%
Solid Malignant Neoplasm
25%
Bleeding
25%
Anemia
25%
Non-Hodgkin Lymphoma
25%
Lymphoproliferative Disease
25%
Splenomegaly
25%
Abdominal Pain
25%
Benign Tumor
25%
Positron Emission Tomography
25%
Surgical Mortality
25%
Plasma Cell Granuloma
25%
Abdominal Mass
25%
Stomach Tissue
25%
Pancreas Tissue
25%
Benign Tumor
25%